 | • レポートコード：QYR2104Z4417 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、膵臓がん治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（生物学、化学療法、標的療法、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・膵臓がん治療の市場動向 ・企業の競争状況、市場シェア ・膵臓がん治療の種類別市場規模（生物学、化学療法、標的療法、その他） ・膵臓がん治療の用途別市場規模（病院、診療所、その他） ・膵臓がん治療の北米市場規模2016-2027（アメリカ、カナダ） ・膵臓がん治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・膵臓がん治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・膵臓がん治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・膵臓がん治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Eli Lilly、Roche、Pfizer、Merck、Celgene、Novartis、Amgen、Teva Pharmaceutical、PharmaCyte Biotech、Clovis Oncology） ・結論 |
Pancreatic cancer therapy is recommended by clinicians for early detection of cancer. Pancreatic cancer generally diagnosed at a later stage, since the symptoms are not easily detected or diagnosed. Factors such as, chronic inflammation of the pancreas (pancreatitis), diabetes, smoking, and obesity are some of the identified causes of pancreatic cancer.
In May 2018, Eli Lilly and Company acquired AMRO BioSciences. AMRO BioSciences is engaged into number of drugs for cancer. The clinical trial explores a drug (pegilodecakin) which is ongoing for the pancreatic cancer. The drug is into phase III of the clinical trials. The acquisition will enhance the therapy products for the Eli Lilly and Company.
Market Analysis and Insights: Global Pancreatic Cancer Therapy Market
The global Pancreatic Cancer Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pancreatic Cancer Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pancreatic Cancer Therapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pancreatic Cancer Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pancreatic Cancer Therapy market.
Global Pancreatic Cancer Therapy Scope and Market Size
Pancreatic Cancer Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pancreatic Cancer Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Biology
Chemotherapy
Targeted Therapy
Others
Segment by Application
Hospitals
Clinics
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Eli Lilly
Roche
Pfizer
Merck
Celgene
Novartis
Amgen
Teva Pharmaceutical
PharmaCyte Biotech
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pancreatic Cancer Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Biology
1.2.3 Chemotherapy
1.2.4 Targeted Therapy
1.2.5 Others
1.3 Market by Application
1.3.1 Global Pancreatic Cancer Therapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Pancreatic Cancer Therapy Market Perspective (2016-2027)
2.2 Pancreatic Cancer Therapy Growth Trends by Regions
2.2.1 Pancreatic Cancer Therapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Pancreatic Cancer Therapy Historic Market Share by Regions (2016-2021)
2.2.3 Pancreatic Cancer Therapy Forecasted Market Size by Regions (2022-2027)
2.3 Pancreatic Cancer Therapy Industry Dynamic
2.3.1 Pancreatic Cancer Therapy Market Trends
2.3.2 Pancreatic Cancer Therapy Market Drivers
2.3.3 Pancreatic Cancer Therapy Market Challenges
2.3.4 Pancreatic Cancer Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pancreatic Cancer Therapy Players by Revenue
3.1.1 Global Top Pancreatic Cancer Therapy Players by Revenue (2016-2021)
3.1.2 Global Pancreatic Cancer Therapy Revenue Market Share by Players (2016-2021)
3.2 Global Pancreatic Cancer Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Pancreatic Cancer Therapy Revenue
3.4 Global Pancreatic Cancer Therapy Market Concentration Ratio
3.4.1 Global Pancreatic Cancer Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pancreatic Cancer Therapy Revenue in 2020
3.5 Pancreatic Cancer Therapy Key Players Head office and Area Served
3.6 Key Players Pancreatic Cancer Therapy Product Solution and Service
3.7 Date of Enter into Pancreatic Cancer Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pancreatic Cancer Therapy Breakdown Data by Type
4.1 Global Pancreatic Cancer Therapy Historic Market Size by Type (2016-2021)
4.2 Global Pancreatic Cancer Therapy Forecasted Market Size by Type (2022-2027)
5 Pancreatic Cancer Therapy Breakdown Data by Application
5.1 Global Pancreatic Cancer Therapy Historic Market Size by Application (2016-2021)
5.2 Global Pancreatic Cancer Therapy Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Pancreatic Cancer Therapy Market Size (2016-2027)
6.2 North America Pancreatic Cancer Therapy Market Size by Type
6.2.1 North America Pancreatic Cancer Therapy Market Size by Type (2016-2021)
6.2.2 North America Pancreatic Cancer Therapy Market Size by Type (2022-2027)
6.2.3 North America Pancreatic Cancer Therapy Market Size by Type (2016-2027)
6.3 North America Pancreatic Cancer Therapy Market Size by Application
6.3.1 North America Pancreatic Cancer Therapy Market Size by Application (2016-2021)
6.3.2 North America Pancreatic Cancer Therapy Market Size by Application (2022-2027)
6.3.3 North America Pancreatic Cancer Therapy Market Size by Application (2016-2027)
6.4 North America Pancreatic Cancer Therapy Market Size by Country
6.4.1 North America Pancreatic Cancer Therapy Market Size by Country (2016-2021)
6.4.2 North America Pancreatic Cancer Therapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Pancreatic Cancer Therapy Market Size (2016-2027)
7.2 Europe Pancreatic Cancer Therapy Market Size by Type
7.2.1 Europe Pancreatic Cancer Therapy Market Size by Type (2016-2021)
7.2.2 Europe Pancreatic Cancer Therapy Market Size by Type (2022-2027)
7.2.3 Europe Pancreatic Cancer Therapy Market Size by Type (2016-2027)
7.3 Europe Pancreatic Cancer Therapy Market Size by Application
7.3.1 Europe Pancreatic Cancer Therapy Market Size by Application (2016-2021)
7.3.2 Europe Pancreatic Cancer Therapy Market Size by Application (2022-2027)
7.3.3 Europe Pancreatic Cancer Therapy Market Size by Application (2016-2027)
7.4 Europe Pancreatic Cancer Therapy Market Size by Country
7.4.1 Europe Pancreatic Cancer Therapy Market Size by Country (2016-2021)
7.4.2 Europe Pancreatic Cancer Therapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Pancreatic Cancer Therapy Market Size (2016-2027)
8.2 Asia-Pacific Pancreatic Cancer Therapy Market Size by Type
8.2.1 Asia-Pacific Pancreatic Cancer Therapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Pancreatic Cancer Therapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Pancreatic Cancer Therapy Market Size by Type (2016-2027)
8.3 Asia-Pacific Pancreatic Cancer Therapy Market Size by Application
8.3.1 Asia-Pacific Pancreatic Cancer Therapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Pancreatic Cancer Therapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Pancreatic Cancer Therapy Market Size by Application (2016-2027)
8.4 Asia-Pacific Pancreatic Cancer Therapy Market Size by Region
8.4.1 Asia-Pacific Pancreatic Cancer Therapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Pancreatic Cancer Therapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Pancreatic Cancer Therapy Market Size (2016-2027)
9.2 Latin America Pancreatic Cancer Therapy Market Size by Type
9.2.1 Latin America Pancreatic Cancer Therapy Market Size by Type (2016-2021)
9.2.2 Latin America Pancreatic Cancer Therapy Market Size by Type (2022-2027)
9.2.3 Latin America Pancreatic Cancer Therapy Market Size by Type (2016-2027)
9.3 Latin America Pancreatic Cancer Therapy Market Size by Application
9.3.1 Latin America Pancreatic Cancer Therapy Market Size by Application (2016-2021)
9.3.2 Latin America Pancreatic Cancer Therapy Market Size by Application (2022-2027)
9.3.3 Latin America Pancreatic Cancer Therapy Market Size by Application (2016-2027)
9.4 Latin America Pancreatic Cancer Therapy Market Size by Country
9.4.1 Latin America Pancreatic Cancer Therapy Market Size by Country (2016-2021)
9.4.2 Latin America Pancreatic Cancer Therapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pancreatic Cancer Therapy Market Size (2016-2027)
10.2 Middle East & Africa Pancreatic Cancer Therapy Market Size by Type
10.2.1 Middle East & Africa Pancreatic Cancer Therapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Pancreatic Cancer Therapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Pancreatic Cancer Therapy Market Size by Type (2016-2027)
10.3 Middle East & Africa Pancreatic Cancer Therapy Market Size by Application
10.3.1 Middle East & Africa Pancreatic Cancer Therapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Pancreatic Cancer Therapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Pancreatic Cancer Therapy Market Size by Application (2016-2027)
10.4 Middle East & Africa Pancreatic Cancer Therapy Market Size by Country
10.4.1 Middle East & Africa Pancreatic Cancer Therapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Pancreatic Cancer Therapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Details
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Pancreatic Cancer Therapy Introduction
11.1.4 Eli Lilly Revenue in Pancreatic Cancer Therapy Business (2016-2021)
11.1.5 Eli Lilly Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Pancreatic Cancer Therapy Introduction
11.2.4 Roche Revenue in Pancreatic Cancer Therapy Business (2016-2021)
11.2.5 Roche Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Pancreatic Cancer Therapy Introduction
11.3.4 Pfizer Revenue in Pancreatic Cancer Therapy Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Pancreatic Cancer Therapy Introduction
11.4.4 Merck Revenue in Pancreatic Cancer Therapy Business (2016-2021)
11.4.5 Merck Recent Development
11.5 Celgene
11.5.1 Celgene Company Details
11.5.2 Celgene Business Overview
11.5.3 Celgene Pancreatic Cancer Therapy Introduction
11.5.4 Celgene Revenue in Pancreatic Cancer Therapy Business (2016-2021)
11.5.5 Celgene Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Pancreatic Cancer Therapy Introduction
11.6.4 Novartis Revenue in Pancreatic Cancer Therapy Business (2016-2021)
11.6.5 Novartis Recent Development
11.7 Amgen
11.7.1 Amgen Company Details
11.7.2 Amgen Business Overview
11.7.3 Amgen Pancreatic Cancer Therapy Introduction
11.7.4 Amgen Revenue in Pancreatic Cancer Therapy Business (2016-2021)
11.7.5 Amgen Recent Development
11.8 Teva Pharmaceutical
11.8.1 Teva Pharmaceutical Company Details
11.8.2 Teva Pharmaceutical Business Overview
11.8.3 Teva Pharmaceutical Pancreatic Cancer Therapy Introduction
11.8.4 Teva Pharmaceutical Revenue in Pancreatic Cancer Therapy Business (2016-2021)
11.8.5 Teva Pharmaceutical Recent Development
11.9 PharmaCyte Biotech
11.9.1 PharmaCyte Biotech Company Details
11.9.2 PharmaCyte Biotech Business Overview
11.9.3 PharmaCyte Biotech Pancreatic Cancer Therapy Introduction
11.9.4 PharmaCyte Biotech Revenue in Pancreatic Cancer Therapy Business (2016-2021)
11.9.5 PharmaCyte Biotech Recent Development
11.10 Clovis Oncology
11.10.1 Clovis Oncology Company Details
11.10.2 Clovis Oncology Business Overview
11.10.3 Clovis Oncology Pancreatic Cancer Therapy Introduction
11.10.4 Clovis Oncology Revenue in Pancreatic Cancer Therapy Business (2016-2021)
11.10.5 Clovis Oncology Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Pancreatic Cancer Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Biology
Table 3. Key Players of Chemotherapy
Table 4. Key Players of Targeted Therapy
Table 5. Key Players of Others
Table 6. Global Pancreatic Cancer Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Pancreatic Cancer Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Pancreatic Cancer Therapy Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Pancreatic Cancer Therapy Market Share by Regions (2016-2021)
Table 10. Global Pancreatic Cancer Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Pancreatic Cancer Therapy Market Share by Regions (2022-2027)
Table 12. Pancreatic Cancer Therapy Market Trends
Table 13. Pancreatic Cancer Therapy Market Drivers
Table 14. Pancreatic Cancer Therapy Market Challenges
Table 15. Pancreatic Cancer Therapy Market Restraints
Table 16. Global Pancreatic Cancer Therapy Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Pancreatic Cancer Therapy Market Share by Players (2016-2021)
Table 18. Global Top Pancreatic Cancer Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pancreatic Cancer Therapy as of 2020)
Table 19. Ranking of Global Top Pancreatic Cancer Therapy Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Pancreatic Cancer Therapy Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Pancreatic Cancer Therapy Product Solution and Service
Table 23. Date of Enter into Pancreatic Cancer Therapy Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Pancreatic Cancer Therapy Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Pancreatic Cancer Therapy Revenue Market Share by Type (2016-2021)
Table 27. Global Pancreatic Cancer Therapy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Pancreatic Cancer Therapy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Pancreatic Cancer Therapy Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Pancreatic Cancer Therapy Revenue Market Share by Application (2016-2021)
Table 31. Global Pancreatic Cancer Therapy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Pancreatic Cancer Therapy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Pancreatic Cancer Therapy Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Pancreatic Cancer Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Pancreatic Cancer Therapy Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Pancreatic Cancer Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Pancreatic Cancer Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Pancreatic Cancer Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Pancreatic Cancer Therapy Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Pancreatic Cancer Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Pancreatic Cancer Therapy Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Pancreatic Cancer Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Pancreatic Cancer Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Pancreatic Cancer Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Pancreatic Cancer Therapy Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Pancreatic Cancer Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Pancreatic Cancer Therapy Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Pancreatic Cancer Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Pancreatic Cancer Therapy Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Pancreatic Cancer Therapy Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Pancreatic Cancer Therapy Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Pancreatic Cancer Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Pancreatic Cancer Therapy Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Pancreatic Cancer Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Pancreatic Cancer Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Pancreatic Cancer Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Pancreatic Cancer Therapy Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Pancreatic Cancer Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Pancreatic Cancer Therapy Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Pancreatic Cancer Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Pancreatic Cancer Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Pancreatic Cancer Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 63. Eli Lilly Company Details
Table 64. Eli Lilly Business Overview
Table 65. Eli Lilly Pancreatic Cancer Therapy Product
Table 66. Eli Lilly Revenue in Pancreatic Cancer Therapy Business (2016-2021) & (US$ Million)
Table 67. Eli Lilly Recent Development
Table 68. Roche Company Details
Table 69. Roche Business Overview
Table 70. Roche Pancreatic Cancer Therapy Product
Table 71. Roche Revenue in Pancreatic Cancer Therapy Business (2016-2021) & (US$ Million)
Table 72. Roche Recent Development
Table 73. Pfizer Company Details
Table 74. Pfizer Business Overview
Table 75. Pfizer Pancreatic Cancer Therapy Product
Table 76. Pfizer Revenue in Pancreatic Cancer Therapy Business (2016-2021) & (US$ Million)
Table 77. Pfizer Recent Development
Table 78. Merck Company Details
Table 79. Merck Business Overview
Table 80. Merck Pancreatic Cancer Therapy Product
Table 81. Merck Revenue in Pancreatic Cancer Therapy Business (2016-2021) & (US$ Million)
Table 82. Merck Recent Development
Table 83. Celgene Company Details
Table 84. Celgene Business Overview
Table 85. Celgene Pancreatic Cancer Therapy Product
Table 86. Celgene Revenue in Pancreatic Cancer Therapy Business (2016-2021) & (US$ Million)
Table 87. Celgene Recent Development
Table 88. Novartis Company Details
Table 89. Novartis Business Overview
Table 90. Novartis Pancreatic Cancer Therapy Product
Table 91. Novartis Revenue in Pancreatic Cancer Therapy Business (2016-2021) & (US$ Million)
Table 92. Novartis Recent Development
Table 93. Amgen Company Details
Table 94. Amgen Business Overview
Table 95. Amgen Pancreatic Cancer Therapy Product
Table 96. Amgen Revenue in Pancreatic Cancer Therapy Business (2016-2021) & (US$ Million)
Table 97. Amgen Recent Development
Table 98. Teva Pharmaceutical Company Details
Table 99. Teva Pharmaceutical Business Overview
Table 100. Teva Pharmaceutical Revenue in Pancreatic Cancer Therapy Business (2016-2021) & (US$ Million)
Table 101. Teva Pharmaceutical Recent Development
Table 102. PharmaCyte Biotech Company Details
Table 103. PharmaCyte Biotech Business Overview
Table 104. PharmaCyte Biotech Pancreatic Cancer Therapy Product
Table 105. PharmaCyte Biotech Revenue in Pancreatic Cancer Therapy Business (2016-2021) & (US$ Million)
Table 106. PharmaCyte Biotech Recent Development
Table 107. Clovis Oncology Company Details
Table 108. Clovis Oncology Business Overview
Table 109. Clovis Oncology Pancreatic Cancer Therapy Product
Table 110. Clovis Oncology Revenue in Pancreatic Cancer Therapy Business (2016-2021) & (US$ Million)
Table 111. Clovis Oncology Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pancreatic Cancer Therapy Market Share by Type: 2020 VS 2027
Figure 2. Biology Features
Figure 3. Chemotherapy Features
Figure 4. Targeted Therapy Features
Figure 5. Others Features
Figure 6. Global Pancreatic Cancer Therapy Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Others Case Studies
Figure 10. Pancreatic Cancer Therapy Report Years Considered
Figure 11. Global Pancreatic Cancer Therapy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Pancreatic Cancer Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Pancreatic Cancer Therapy Market Share by Regions: 2020 VS 2027
Figure 14. Global Pancreatic Cancer Therapy Market Share by Regions (2022-2027)
Figure 15. Global Pancreatic Cancer Therapy Market Share by Players in 2020
Figure 16. Global Top Pancreatic Cancer Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pancreatic Cancer Therapy as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Pancreatic Cancer Therapy Revenue in 2020
Figure 18. Global Pancreatic Cancer Therapy Revenue Market Share by Type (2016-2021)
Figure 19. Global Pancreatic Cancer Therapy Revenue Market Share by Type (2022-2027)
Figure 20. North America Pancreatic Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Pancreatic Cancer Therapy Market Share by Type (2016-2027)
Figure 22. North America Pancreatic Cancer Therapy Market Share by Application (2016-2027)
Figure 23. North America Pancreatic Cancer Therapy Market Share by Country (2016-2027)
Figure 24. United States Pancreatic Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Pancreatic Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Pancreatic Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Pancreatic Cancer Therapy Market Share by Type (2016-2027)
Figure 28. Europe Pancreatic Cancer Therapy Market Share by Application (2016-2027)
Figure 29. Europe Pancreatic Cancer Therapy Market Share by Country (2016-2027)
Figure 30. Germany Pancreatic Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Pancreatic Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Pancreatic Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Pancreatic Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Pancreatic Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Pancreatic Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Pancreatic Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Pancreatic Cancer Therapy Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Pancreatic Cancer Therapy Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Pancreatic Cancer Therapy Market Share by Region (2016-2027)
Figure 40. China Pancreatic Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Pancreatic Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Pancreatic Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Pancreatic Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Pancreatic Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Pancreatic Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Pancreatic Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Pancreatic Cancer Therapy Market Share by Type (2016-2027)
Figure 48. Latin America Pancreatic Cancer Therapy Market Share by Application (2016-2027)
Figure 49. Latin America Pancreatic Cancer Therapy Market Share by Country (2016-2027)
Figure 50. Mexico Pancreatic Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Pancreatic Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Pancreatic Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Pancreatic Cancer Therapy Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Pancreatic Cancer Therapy Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Pancreatic Cancer Therapy Market Share by Country (2016-2027)
Figure 56. Turkey Pancreatic Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Pancreatic Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Pancreatic Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Eli Lilly Revenue Growth Rate in Pancreatic Cancer Therapy Business (2016-2021)
Figure 60. Roche Revenue Growth Rate in Pancreatic Cancer Therapy Business (2016-2021)
Figure 61. Pfizer Revenue Growth Rate in Pancreatic Cancer Therapy Business (2016-2021)
Figure 62. Merck Revenue Growth Rate in Pancreatic Cancer Therapy Business (2016-2021)
Figure 63. Celgene Revenue Growth Rate in Pancreatic Cancer Therapy Business (2016-2021)
Figure 64. Novartis Revenue Growth Rate in Pancreatic Cancer Therapy Business (2016-2021)
Figure 65. Amgen Revenue Growth Rate in Pancreatic Cancer Therapy Business (2016-2021)
Figure 66. Teva Pharmaceutical Revenue Growth Rate in Pancreatic Cancer Therapy Business (2016-2021)
Figure 67. PharmaCyte Biotech Revenue Growth Rate in Pancreatic Cancer Therapy Business (2016-2021)
Figure 68. Clovis Oncology Revenue Growth Rate in Pancreatic Cancer Therapy Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
世界の膵臓がん治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Pancreatic Cancer Treatment Market The global Pancreatic Cancer Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity…- 世界の膵臓がん治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Pancreatic Cancer Treatment Market The global Pancreatic Cancer Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity…
- 世界の膵臓がん治療薬市場規模・現状・予測（2021年-2027年） Pancreatic cancer therapy is recommended by clinicians for early detection of cancer. Pancreatic cancer generally diagnosed at a later stage, since the symptoms are not easily detected or diagnosed. Factors such as, chronic inflammation of the pancreas (pancreatitis), diabetes, smoking, and obesity …
- 世界の膵臓がん診断市場規模・現状・予測（2021年-2027年） Pancreatic cancer arises when cells in the pancreas, a glandular organ behind the stomach, begin to multiply out of control and form a mass. These cancerous cells have the ability to invade other parts of the body. A number of types of pancreatic cancer are known. The most common, pancreatic adenoca…
- 世界の膵臓がん診断市場規模・現状・予測（2021年-2027年） Pancreatic cancer arises when cells in the pancreas, a glandular organ behind the stomach, begin to multiply out of control and form a mass. These cancerous cells have the ability to invade other parts of the body. A number of types of pancreatic cancer are known. The most common, pancreatic adenoca…